The MM&M podcast 1.23.2019: Wunderman Health’s Becky Chidester
Becky Chidester, CEO of Wunderman Health, joins MM&M’s Marc Iskowitz and Larry Dobrow to discuss the integration with WPP, health’s #MeToo moment, and agency evolution in 2019.
-
-
Behind the scenes of Lilly’s ad referencing pricing
Eli Lilly is the first pharma company to react to PhRMA’s revised marketing guidelines, which go into effect in the spring. -
Caris Life Sciences names Srikant Ramaswami chief communications officer
Ramaswami was most recently at rbb Communications and spent much of his career in pharma, including roles at J&J, Pfizer, and Merck. -
MM&M starts 2019 search for Healthcare Transformers, Innovation Catalysts
Honorees will be profiled in the May issue and honored at an event that month in New York.
LATEST NEWS
Five things for pharma marketers to know: Wednesday, January 23, 2019
PhRMA breaks its own lobbying spending record; J&J settles hip implant deceptive marketing suit; Walgreens settles lawsuits for overbilling federal health programs.
Five things for pharma marketers to know: Tuesday, January 22, 2019
J&J beats Q4 expectations, warns of sales slowdown; Behind the scenes of Lilly’s drug pricing ad decision; Cost of diabetes treatments doubled in five years.
Study: Marketing opioids to doctors tied to increased overdose deaths
Researchers looked at the connections between the amount of marketing to doctors and opioid overdose deaths in a study published in JAMA.
Five things for pharma marketers to know: Friday, January 18, 2019
Lawmakers want to end tax exemption for pharma ads; Gottlieb warns of “hard decisions” at FDA if shutdown continues; Feds to allow drugmakers to develop over-the-counter naloxone.
Bill to end tax exemption for pharma marketing introduced in Senate
Sixteen Democratic senators are backing the latest version of a bill to end the exemption for DTC advertising.
Five things for pharma marketers to know: Thursday, January 17, 2019
Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
Kaiser Permanente launches united Permanente Medicine brand
The branding change unifies the eight regional physician groups of the Permanente Medical Group.
GCI Health to open Singapore office, its first in Asia
It’s the first step in a planned regional expansion for GCI.
Five things for pharma marketers to know: Wednesday, January 16, 2019
Court documents detail aggressive marketing of OxyContin; Walgreens partners with Microsoft on research; Allergan wants High Court to take up Restasis patent lawsuit.
Five things for pharma marketers to know: Tuesday, January 15, 2019
Walmart pharmacies set to leave CVS network; Edwards Lifesciences settles patent dispute with Boston Scientific; Pfizer to cut 150 R&D jobs.
